Getting spending on Social Security, Medicare, and Medicaid “under control” is at the top of all the budgeteers’ agenda. While the intention sounds reasonable, spending on these programs is ...
Dubai Chamber of Commerce, one of the three chambers operating under the umbrella of Dubai Chambers, has revealed that Indian investors topped the list of nationalities behind new companies joining ...
AstraZeneca (AZN) joins Johnson & Johnson (JNJ), Merck (MRK), and Bristol-Myers (BMY) in a lawsuit against the U.S. Department of Health and Human Services (HHS) over certain provisions on prices ...
Japanese drugmaker Astellas (OTCPK:ALPMF) has withdrawn a federal lawsuit that challenged the US government’s right to negotiate drug prices for its Medicare program, but maintained the newly ...
AARP announced Thursday it would join the US government in two additional lawsuits brought by drug companies suing over Medicare drug pricing negotiations, which are set to begin next month.
AARP announced Thursday it would join the US government in two additional lawsuits brought by drug companies suing over Medicare drug pricing negotiations, which are set to begin next month.
While only slightly past the midway point of 2023, it has already been a busy year for developments in drug pricing. Notably, CMS released its final guidance in preparation for price negotiations ...
A group of Republicans has called the Biden administration's list of the first 10 drugs that will face Medicare price negotiations a form of price controls that will end up leading to fewer new ...
Aug 31 (Reuters) - Drugmakers challenging a Biden administration program requiring them to negotiate with Medicare over the prices of selected costly drugs may not have a clear legal precedent on ...
AstraZeneca joins Johnson & Johnson (), Merck (), and Bristol-Myers in a lawsuit against the U.S. Department of Health and Human Services (HHS) over certain provisions on prices found in President ...
The maker of widely used blood thinner Eliquis on Friday sued the U.S. government over a provision in the Inflation Reduction Act that would let Medicare negotiate drug prices, becoming the second ...
(Reuters) - The U.S. Chamber of Commerce on Friday sued the federal government, challenging a new law that for the first time gives Medicare the power to negotiate drug prices with pharmaceutical ...
